Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2025-12-24 @ 11:11 PM
NCT ID:
NCT02028169
Eligibility Criteria:
Inclusion Criteria:
* Actively working, either full-time or part-time
* Previous confirmed diagnosis of PsA by a rheumatologist
* Patients for whom the physician has initiated PsA treatment with an Anti-TNF in accordance with Turkish Ministry of Health regulations and reimbursement criteria
* Able to provide authorization to use and disclose their health related information
Exclusion Criteria:
* Patients with a history of an allergic reaction or significant sensitivity to anti-TNF agents
* Patients with possible follow-up problems during the planned study period or patients who may not be compliant to treatment as evaluated by the investigator/treating physician
* Patients participating in any clinical trial of an experimental drug 30 days prior to the baseline visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT02028169
Study Brief:
Protocol Section:
NCT02028169